LB Pharma seeks $228M in proposed IPO with hopes to be industry’s first since Februarynews2025-09-08T14:58:58+00:00September 8th, 2025|Endpoints News|
Exclusive: Cancer care startup Daymark Health raises $20Mnews2025-09-08T14:49:51+00:00September 8th, 2025|Endpoints News|
BridgeBio’s Phase 2 hypoparathyroidism data; FDA clears second pig kidney trialnews2025-09-08T14:11:52+00:00September 8th, 2025|Endpoints News|
Biotech vet Harvey Berger steps into CEO role at Arena BioWorksnews2025-09-08T11:00:33+00:00September 8th, 2025|Endpoints News|
Rapport reveals promising open-label study data for epilepsy pill, heads to Phase 3news2025-09-08T10:00:35+00:00September 8th, 2025|Endpoints News|
#WCLC25: AstraZeneca’s Tagrisso combo extends survival by 10 months in EGFR-mutant lung cancernews2025-09-08T08:22:44+00:00September 8th, 2025|Endpoints News|
#WorldSleep2025: Alkermes’ success in Phase 2 narcolepsy trial is clouded by side effectsnews2025-09-08T07:15:52+00:00September 8th, 2025|Endpoints News|
#WorldSleep2025: Takeda’s Phase 3 narcolepsy results could make it first mover in multibillion-dollar marketnews2025-09-08T07:15:19+00:00September 8th, 2025|Endpoints News|
Mitochondrial startup gets £50M to test lead drug in ALS, Parkinson’snews2025-09-08T07:00:40+00:00September 8th, 2025|Endpoints News|
Servier buys Medicxi startup’s fragile X candidate for up to $450Mnews2025-09-08T06:30:05+00:00September 8th, 2025|Endpoints News|
